Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Change in Intangibles: 2013-2019

  • Amphastar Pharmaceuticals' Change in Intangibles fell 96.57% to $151,000 in Q1 2019 from the same period last year, while for Mar 2019 it was $6.6 million, marking a year-over-year increase of 2.12%. This contributed to the annual value of $4.4 million for FY2018, which is 120.00% up from last year.
  • Amphastar Pharmaceuticals' Change in Intangibles amounted to $151,000 in Q1 2019, which was down 96.57% from $4.4 million recorded in Q1 2018.
  • In the past 5 years, Amphastar Pharmaceuticals' Change in Intangibles ranged from a high of $4.4 million in Q1 2018 and a low of $151,000 during Q1 2019.
  • Its 3-year average for Change in Intangibles is $1.6 million, with a median of $1.0 million in 2017.
  • Its Change in Intangibles has fluctuated over the past 5 years, first surged by 340.00% in 2018, then crashed by 96.57% in 2019.
  • Amphastar Pharmaceuticals' Change in Intangibles (Quarterly) stood at $1.0 million in 2017, then spiked by 340.00% to $4.4 million in 2018, then tumbled by 96.57% to $151,000 in 2019.
  • Its Change in Intangibles was $151,000 in Q1 2019, compared to $4.4 million in Q1 2018 and $1.0 million in Q2 2017.